Spots Global Cancer Trial Database for The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a BRCA Gene Mutation.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a BRCA Gene Mutation.
Official Title: An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a BRCA Gene Mutation (GENPET)
Study ID: NCT05097274
Study Description
Brief Summary: The aim of the study is to determine if PET-CT imaging (using contrast recommended in clinical guidelines) is superior to combined bone scan and MRI/CT of the abdomen \& pelvis in detecting the increased incidence of metastasis (nodal/distant outside the pelvis) in men with prostatic carcinoma with germline BRCA mutations.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Cancer Genetics Unit, Royal Marsden Hospital, London, Sutton, Surrey, United Kingdom
Contact Details
Name: Rosalind A Eeles, FRCP FRCR
Affiliation: Institute of Cancer Research and Royal Marsden Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
